Avidity Partners Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,053,300
| Closed | -$13.2M | – | 79 |
|
|
2024
Q4 | $13.2M | Buy |
1,053,300
+304,300
| +41% | +$3.83M | 1.3% | 33 |
|
|
2024
Q3 | $13.8M | Sell |
749,000
-351,000
| -32% | -$6.48M | 0.71% | 53 |
|
|
2024
Q2 | $23.7M | Buy |
1,100,000
+75,000
| +7% | +$1.61M | 1.01% | 43 |
|
|
2024
Q1 | $27.6M | Sell |
1,025,000
-694,103
| -40% | -$18.7M | 0.89% | 38 |
|
|
2023
Q4 | $51.5M | Buy |
1,719,103
+131,674
| +8% | +$3.95M | 1.88% | 19 |
|
|
2023
Q3 | $32.5M | Buy |
1,587,429
+261,429
| +20% | +$5.36M | 1.31% | 36 |
|
|
2023
Q2 | $26.3M | Buy |
1,326,000
+81,600
| +7% | +$1.62M | 0.92% | 45 |
|
|
2023
Q1 | $21.3M | Sell |
1,244,400
-282,687
| -19% | -$4.84M | 0.71% | 45 |
|
|
2022
Q4 | $29.9M | Buy |
+1,527,087
| New | +$29.9M | 0.65% | 43 |
|
|
2021
Q1 | – | Sell |
-50,000
| Closed | -$2.74M | – | 118 |
|
|
2020
Q4 | $2.74M | Buy |
+50,000
| New | +$2.74M | 0.09% | 87 |
|
|
2020
Q1 | – | Sell |
-30,000
| Closed | -$683K | – | 60 |
|
|
2019
Q4 | $683K | Buy |
+30,000
| New | +$683K | 0.43% | 30 |
|